HealthTrending
FDA requires NAION warning labels on all GLP-1 medications
The FDA is requiring all GLP-1 drugs, including Ozempic, Wegovy, Mounjaro and Zepbound, to carry a warning about a rare eye condition that can cause permanent vision loss.
Checked against 6 sourcesThe Guardianinkl.comcbsnews.com+3 more
